Reports
Global Bronchiectasis Drugs Market: By Product: Antibiotics, Expectorants, Other Drugs; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, EMR’s Key Indicators for Demand, EMR’s Key Indicators for Price; Competitive Landscape; Industry Events and Developments
Global Bronchiectasis Drugs Market Outlook
The global bronchiectasis drugs market size is projected to expand by USD 126.75 million between 2021 and 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Conventional techniques used to diagnose bacterial lung infection have several constraints, including failure to accurately identify the cause of infection and failure to provide a full representation of the bacterial load present in the lungs, thus, leading to the development of advanced technologies like high-resolution computed tomography (HRCT) scan, aiding the bronchiectasis drugs market. Further, the availability of low-cost drugs is one of the major factors aiding the bronchiectasis drugs industry, globally.
Market Segmentation
Bronchiectasis can lead to a build-up of excess mucous, making the lungs more vulnerable to infection. The major method to treat bronchiectasis remains the use of antibiotics to avoid infection.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry can be broadly categorised on the basis of its product into:
- Antibiotics
- Expectorants
- Others
The EMR report looks into the regional bronchiectasis drugs markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The high-resolution computed tomography (HRCT) scan has emerged as popular technique to diagnose bronchiectasis and other respiratory diseases. Such developments in respiratory disease diagnostics will allow pulmonologists and otolaryngologists to accurately define the disease phase and provide patients with suitable and timely therapy and medicines. This trend will have a positive effect over the forecast period on bronchiectasis drugs market growth. Further, the accessibility to low-cost and off-label generic drugs is one of the major factors responsible for the development of the market. Generic drug contains the same active pharmaceutical ingredient (API) as branded drugs and are less expensive than branded drugs. The availability of such low-priced drugs, combined with rising bronchiectasis incidence, will increase therapeutic adoption rates, particularly in underdeveloped and developing countries. The approval of these low-cost generics will further increase the growth opportunities for market.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global bronchiectasis drugs market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Endo International Plc [NASDAQ: ENDP]
- GlaxoSmithKline Plc [LON: GSK]
- Neopharma LLC
- Pfizer Inc. [NYSE: PFE]
- Reckitt Benckiser Group Plc [LON: RB]
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Region |
| Breakup by Product | Antibiotics, Expectorants, Other Drugs |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Endo International Plc [ENDP (NASDAQ)], GlaxoSmithKline Plc [GSK (LON)], Neopharma LLC, Pfizer Inc. [PFE (NYSE)], Reckitt Benckiser Group Plc [RB (LON)], Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Bronchiectasis Drugs Market Analysis
8.1 Key Industry Highlights
8.2 Global Bronchiectasis Drugs Historical Market (2018-2022)
8.3 Global Bronchiectasis Drugs Market Forecast (2023-2028)
8.4 Global Bronchiectasis Drugs Market by Product
8.4.1 Antibiotics
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Expectorants
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Other Drugs
8.5 Global Bronchiectasis Drugs Market by Region
8.5.1 Market Share
8.5.1.1 North America
8.5.1.2 Europe
8.5.1.3 Asia Pacific
8.5.1.4 Latin America
8.5.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Spain
9.2.3.6 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 GlaxoSmithKline Plc (LON: GSK)
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Neopharma LLC
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Pfizer Inc. (NYSE: PFE)
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Reckitt Benckiser Group Plc (LON: RB)
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Bronchiectasis Drugs Market: Key Industry Highlights, 2018 and 2028
2. Global Bronchiectasis Drugs Historical Market: Breakup by Product (USD Million), 2018-2022
3. Global Bronchiectasis Drugs Market Forecast: Breakup by Product (USD Million), 2023-2028
4. Global Bronchiectasis Drugs Historical Market: Breakup by Region (USD Million), 2018-2022
5. Global Bronchiectasis Drugs Market Forecast: Breakup by Region (USD Million), 2023-2028
6. North America Bronchiectasis Drugs Historical Market: Breakup by Country (USD Million), 2018-2022
7. North America Bronchiectasis Drugs Market Forecast: Breakup by Country (USD Million), 2023-2028
8. Europe Bronchiectasis Drugs Historical Market: Breakup by Country (USD Million), 2018-2022
9. Europe Bronchiectasis Drugs Market Forecast: Breakup by Country (USD Million), 2023-2028
10. Asia Pacific Bronchiectasis Drugs Historical Market: Breakup by Country (USD Million), 2018-2022
11. Asia Pacific Bronchiectasis Drugs Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Latin America Bronchiectasis Drugs Historical Market: Breakup by Country (USD Million), 2018-2022
13. Latin America Bronchiectasis Drugs Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Middle East and Africa Bronchiectasis Drugs Historical Market: Breakup by Country (USD Million), 2018-2022
15. Middle East and Africa Bronchiectasis Drugs Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Global Bronchiectasis Drugs Market Structure
Key Questions Answered in the Report
The global bronchiectasis drugs market is projected to grow by USD 126.75 million between 2021 and 2026.
The major drivers of the market include the several constraints of conventional techniques used to diagnose bacterial lung infection and the rising pharmaceutical industry.
Availability of low-cost drugs is the key industry trend propelling the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading products in the market are antibiotics, expectorants, and other drugs.
The major players in the industry are GlaxoSmithKline Plc, Neopharma LLC, Pfizer Inc., and Reckitt Benckiser Group Plc, among others.
Analyst Review
Aided by the rising investments into the healthcare sector, the global bronchiectasis drugs market is expected to witness a healthy growth in the forecast period of 2023-2028 and expand by USD 126.75 million.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on product, the bronchiectasis drugs industry can be segmented into antibiotics, expectorants, and other drugs. The major regional markets for bronchiectasis drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Endo International Plc, GlaxoSmithKline Plc, Neopharma LLC, Pfizer Inc., Reckitt Benckiser Group Plc, and others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER